Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Researchers are exploring whether GLP-1 medications used for diabetes and weight loss could treat Alzheimers and addiction, but public concerns persist about long-term safety
GLP-1s and the weight loss they drive tend to pull fat out of the liver, and ALT and AST often improve as a result
Glucagon does something neither GLP-1 nor GIP can do: it increases energy expenditure
obesity epidemic and its direct linkage to Type 2 diabetes, a medical tradeoff could be rationalized for this drug to be a primary treatment option for diabetes
In a year filled with gridlock for biomedical research and public health, your voice kept ME/CFS on the agenda
S., & McCann, S
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
US$ 23.84
